Upadacitinib 30 mg for the optimal management of moderate-to-severe atopic dermatitis: a 52-week single-center real-world study

被引：8

作者：

Gargiulo, Luigi ^{[1
,2
]}

Ibba, Luciano ^{[1
,2
]}

Bianco, Matteo ^{[1
,2
]}

Di Giulio, Sara ^{[1
,2
]}

Alfano, Alfano ^{[1
,2
]}

Ingurgio, Ruggero Cascio ^{[1
,2
]}

Facheris, Paola ^{[1
]}

Perugini, Chiara ^{[1
]}

Valenti, Mario ^{[1
,2
]}

Costanzo, Antonio ^{[1
,2
]}

Narcisi, Alessandra ^{[1
]}

机构：

[1] IRCCS Humanitas Res Hosp, Dermatol Unit, Rozzano, Italy

[2] Humanitas Univ, Dept Biomed Sci, Pieve Emanuele, Italy

来源：

JOURNAL OF DERMATOLOGICAL TREATMENT | 2024年 / 35卷 / 01期

关键词：

DOUBLE-BLIND; ADOLESCENTS; PLACEBO; ADULTS; SAFETY;

D O I：

10.1080/09546634.2024.2375102

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页数：3

共 11 条

[1]

European Medicines Agency, 2019, RINVOQ UPADACITINIB

[2] Effectiveness and safety of upadacitinib for moderate-to-severe atopic dermatitis in a real-world setting: A 52-week retrospective study [J].

Gargiulo, L. ;

Ibba, L. ;

Piscazzi, F. ;

Alfano, A. ;

Ingurgio, R. Cascio ;

Valenti, M. ;

Costanzo, A. ;

Narcisi, A. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (02) :e152-e154

[3] Management of Patients Affected by Moderate-to-Severe Atopic Dermatitis with JAK Inhibitors in Real-World Clinical Practice: An Italian Delphi Consensus [J].

Gargiulo, Luigi ;

Ibba, Luciano ;

Malagoli, Piergiorgio ;

Burroni, Anna G. ;

Chiricozzi, Andrea ;

Dapavo, Paolo ;

Ferrucci, Silvia M. ;

Gola, Massimo ;

Napolitano, Maddalena ;

Ortoncelli, Michela ;

Rossi, Maria T. ;

Sciarrone, Claudio ;

Costanzo, Antonio ;

Narcisi, Alessandra .

DERMATOLOGY AND THERAPY, 2024, 14 (04) :919-932

[4] Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double- blind, randomised controlled phase 3 trials [J].

Guttman-Yassky, Emma ;

Teixeira, Henrique D. ;

Simpson, Eric L. ;

Papp, Kim A. ;

Pangan, Aileen L. ;

Blauvelt, Andrew ;

Thaci, Diamant ;

Chu, Chia-Yu ;

Hong, H. Chih-Ho ;

Katoh, Norito ;

Paller, Amy S. ;

Calimlim, Brian ;

Gu, Yihua ;

Hu, Xiaofei ;

Liu, Meng ;

Yang, Yang ;

Liu, John ;

Tenorio, Allan R. ;

Chu, Alvina D. ;

Irvine, Alan D. .

LANCET, 2021, 397 (10290) :2151-2168

[5] Sustained Effectiveness of Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A 48-Week Real-World Study [J].

Hagino, Teppei ;

Hamada, Risa ;

Yoshida, Mai ;

Saeki, Hidehisa ;

Fujimoto, Eita ;

Kanda, Naoko .

PHARMACEUTICALS, 2024, 17 (04)

[6] Long-term effectiveness and safety of upadacitinib for Japanese patients with moderate-to-severe atopic dermatitis: a real-world clinical study [J].

Hagino, Teppei ;

Saeki, Hidehisa ;

Fujimoto, Eita ;

Kanda, Naoko .

JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)

[7] The efficacy and safety of upadacitinib treatment for moderate to severe atopic dermatitis in real-world practice in Japan [J].

Hagino, Teppei ;

Saeki, Hidehisa ;

Kanda, Naoko .

JOURNAL OF DERMATOLOGY, 2022, 49 (11) :1158-1167

[8] Practical Use of Upadacitinib in Patients with Severe Atopic Dermatitis in a Real-World Setting: A Systematic Review [J].

Ibba, Luciano ;

Gargiulo, Luigi ;

Vignoli, Carlo Alberto ;

Fiorillo, Giovanni ;

Valenti, Mario ;

Costanzo, Antonio ;

Narcisi, Alessandra .

CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2024, 17 :593-604

[9] Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial [J].

Reich, Kristian ;

Teixeira, Henrique D. ;

de Bruin-Weller, Marjolein ;

Bieber, Thomas ;

Soong, Weily ;

Kabashima, Kenji ;

Werfel, Thomas ;

Zeng, Jiewei ;

Huang, Xiaohong ;

Hu, Xiaofei ;

Hendrickson, Barbara A. ;

Ladizinski, Barry ;

Chu, Alvina D. ;

Silverberg, Jonathan I. .

LANCET, 2021, 397 (10290) :2169-2181

[10] Optimizing the management of atopic dermatitis with a new minimal disease activity concept and criteria and consensus-based recommendations for systemic therapy [J].

Silverberg, Jonathan, I ;

Gooderham, Melinda ;

Katoh, Norito ;

Aoki, Valeria ;

Pink, Andrew E. ;

Binamer, Yousef ;

Wollenberg, Andreas .

BRITISH JOURNAL OF DERMATOLOGY, 2023, 188

← 1 2 →